Repke, DB; Ferguson, WJ; Bates, DK. Psilocin analogs. 1. Synthesis of 3-[2-(dialkylamino)ethyl]- and 3-[2-(cycloalkylamino)ethyl]indol-4-ols. J. Heterocycl. Chem., 1 Jan 1977, 14 (1), 71–74. 273 kB. https://doi.org/10.1002/jhet.5570140113
Brandt, SD; Martins, CPB. Analytical methods for psychoactive N,N-dialkylated tryptamines. Trends Anal. Chem., 1 Sep 2010, 29 (8), 858–869. 446 kB. https://doi.org/10.1016/j.trac.2010.04.008 #19
EMCDDA. New drugs in Europe, 2012, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2013. 773 kB. #33
Chapman, SJ. PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra. BLOTTER, 1 Mar 2018, 3 (1). 1.2 MB. https://doi.org/10.16889/isomerdesign-5
Chapman, SJ. PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra. Supplementary Data. BLOTTER, 1 Mar 2018, 3 (1). 5.7 MB. https://doi.org/10.16889/isomerdesign-5-supp
Shulgin, AT. Basic Pharmacology and Effects. In Hallucinogens. A Forensic Drug Handbook; Laing, R; Siegel, JA, Eds., Academic Press, London, 24 Apr 2003; pp 67–137. 6.3 MB.
Palamar, JJ; Acosta, P. A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines. Hum. Psychopharmacol. Clin. Exp., 1 Jan 2020, 35 (1), e2719. 764 kB. https://doi.org/10.1002/hup.2719 #4-HO-DPT
Klein, AK; Chatha, M; Laskowski, LJ; Anderson, EI; Brandt, SD; Chapman, SJ; McCorvy, JD; Halberstadt, AL. Investigation of the structure–activity relationships of psilocybin analogues. ACS Pharmacol. Transl. Sci., 9 Apr 2021, 4 (2), 533-542. 1.9 MB. https://doi.org/10.1021/acsptsci.0c00176 #4-HO-DPT
Tanaka, R; Kawamura, M; Hakamatsuka, T; Kikura-Hanajiri, R. Identification of six tryptamine derivatives as designer drugs in illegal products. Forensic Toxicol., 1 Jan 2021, 39 (1), 248-258. 997 kB. https://doi.org/10.1007/s11419-020-00556-5 #2 MS,NMR,UV
4-HO-DIPT · 4-Hydroxy-N,N-diisopropyltryptamine
1-Isopropyl-5-MeO-DMT · 1-Isopropyl-5-methoxy-N,N-dimethyltryptamine
5-MeO-EIPT · 5-Methoxy-N-ethyl-N-isopropyltryptamine
5-HO-DIPT · 5-Hydroxy-N,N-diisopropyltryptamine
5-MeO-EPT · 5-Methoxy-N-ethyl-N-propyltryptamine
5-EtO-MIPT · 5-Ethoxy-N-methyl-N-isopropyltryptamine
5-EtO-MPT · 5-Ethoxy-N-methyl-N-propyltryptamine
5-EtO-DET · 5-Ethoxy-N,N-diethyltryptamine
2-Methyl-5-MeO-MIPT · 2-Methyl-5-methoxy-N-methyl-N-isopropyltryptamine
2-Methyl-5-MeO-MIPT · 2-Methyl-5-methoxy-N-methyl-N-isopropyltryptamine
2-Methyl-5-MeO-DET · 2-Methyl-5-methoxy-N,N-diethyltryptamine
5-MeO-MIBT · 5-Methoxy-N-methyl-N-isobutyltryptamine
5-HO-DPT · 5-Hydroxy-N,N-dipropyltryptamine
5-MeO-MBT · 5-Methoxy-N-methyl-N-butyltryptamine
2-Propyl-5-MeO-DMT · 2-Propyl-5-methoxy-N,N-dimethyltryptamine
1-Propyl-5-MeO-DMT · 1-Propyl-5-methoxy-N,N-dimethyltryptamine
5-Hexyloxy-T · 5-Hexyloxytryptamine
5-Pentyloxy-N-methyltryptamine · 5-Pentyloxy-NMT
N,N-Dipropyltryptamine N-oxide · DPT N-oxide
4-HO-PIPT · 4-Hydroxy-N-propyl-N-isopropyltryptamine